CytImmune Sciences Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 15

CytImmune Sciences General Information

Description

Developer of a nano-medicine platform designed to discover and develop multifunctional tumor-targeted therapies for patients. The company's platform uses Aurimune which is engineered to travel safely and stealthily throughout the body and enter tumors when they are at a vulnerable point, enabling medical professionals to expand their clinical benefit to various toxic anti-cancer therapies.

Contact Information

Website
www.cytimmune.com
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 15010 Broschart Road
  • Suite 180
  • Rockville, MD 20850
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • 15010 Broschart Road
  • Suite 180
  • Rockville, MD 20850
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytImmune Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CytImmune Sciences‘s full profile, request access.

Request a free trial

CytImmune Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nano-medicine platform designed to discover and develop multifunctional tumor-targeted therapies for pati
Drug Discovery
Rockville, MD
7 As of 2023

Maastricht, Netherlands
 

Middleton, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CytImmune Sciences Competitors (48)

One of CytImmune Sciences’s 48 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Centrose Venture Capital-Backed Middleton, WI
Kymera Therapeutics Formerly VC-backed Watertown, MA
Nanospectra Venture Capital-Backed Houston, TX
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 48 competitors. Get the full list »

CytImmune Sciences Patents

  • 94

    Total Documents Applications and Grants

  • Total Patents Families

  • 28

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

CytImmune Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250034221-A1 Cytokine compositions and methods of use thereof Pending 25-Jul-2023
US-20140220133-A1 Nanotechnology based medicine for biodefense Inactive 28-Nov-2012
EP-2219458-A1 Compositions and methods for generating antibodies Active 08-Nov-2007
CA-2706700-A1 Compositions and methods for generating antibodies Inactive 08-Nov-2007
CA-2742388-C Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents Active 08-Nov-2007 C07D305/14
To view CytImmune Sciences’s complete patent history, request access »

CytImmune Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CytImmune Sciences FAQs

  • When was CytImmune Sciences founded?

    CytImmune Sciences was founded in 1988.

  • Where is CytImmune Sciences headquartered?

    CytImmune Sciences is headquartered in Rockville, MD.

  • What is the size of CytImmune Sciences?

    CytImmune Sciences has 7 total employees.

  • What industry is CytImmune Sciences in?

    CytImmune Sciences’s primary industry is Drug Discovery.

  • Is CytImmune Sciences a private or public company?

    CytImmune Sciences is a Private company.

  • What is CytImmune Sciences’s current revenue?

    The current revenue for CytImmune Sciences is .

  • How much funding has CytImmune Sciences raised over time?

    CytImmune Sciences has raised $12.2M.

  • Who are CytImmune Sciences’s competitors?

    Cristal Therapeutics, Centrose, Kymera Therapeutics, Nanospectra, and Marengo Therapeutics are some of the 48 competitors of CytImmune Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »